Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Teva
Julphar
Mallinckrodt
Novartis
Farmers Insurance
Argus Health
Medtronic
Covington
Federal Trade Commission

Generated: August 20, 2017

DrugPatentWatch Database Preview

Hydrocortisone acetate; pramoxine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrocortisone acetate; pramoxine hydrochloride and what is the scope of hydrocortisone acetate; pramoxine hydrochloride patent protection?

Hydrocortisone acetate; pramoxine hydrochloride
is the generic ingredient in four branded drugs marketed by Ferndale Labs, Vintage Pharms, Mylan Speciality Lp, and Sebela Ireland Ltd, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty drug master file entries for hydrocortisone acetate; pramoxine hydrochloride. Four suppliers are listed for this compound.

Summary for Generic Name: hydrocortisone acetate; pramoxine hydrochloride

Tradenames:4
Patents:0
Applicants:4
NDAs:8
Drug Master File Entries: see list60
Suppliers / Packagers: see list4
Clinical Trials: see list3,405
Therapeutic Class:Dermatological Agents
Drug Prices:see low prices
DailyMed Link:hydrocortisone acetate; pramoxine hydrochloride at DailyMed

Pharmacology for Ingredient: hydrocortisone acetate; pramoxine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp
PROCTOFOAM HC
hydrocortisone acetate; pramoxine hydrochloride
AEROSOL, METERED;TOPICAL086195-001Approved Prior to Jan 1, 1982BXRXNoNo► Subscribe► Subscribe► Subscribe
Vintage Pharms
HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROCHLORIDE 1%
hydrocortisone acetate; pramoxine hydrochloride
AEROSOL, METERED;TOPICAL089440-001May 17, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Sebela Ireland Ltd
PRAMOSONE
hydrocortisone acetate; pramoxine hydrochloride
CREAM;TOPICAL085368-001Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe
Sebela Ireland Ltd
PRAMOSONE
hydrocortisone acetate; pramoxine hydrochloride
CREAM;TOPICAL083778-001Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe
Sebela Ireland Ltd
PRAMOSONE
hydrocortisone acetate; pramoxine hydrochloride
LOTION;TOPICAL085979-001Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Baxter
Cerilliant
Cipla
Harvard Business School
Medtronic
Express Scripts
Merck
UBS
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot